Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CVS Health Corporation stock logo
CVS
CVS Health
$89.37
-0.5%
$89.65
$69.51
▼
$110.68
$114.32B0.5811.03 million shs8.02 million shs
Haemonetics Corporation stock logo
HAE
Haemonetics
$123.16
+0.4%
$113.34
$51.00
▼
$132.00
$5.60B0.62685,220 shs439,677 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$2.33
-27.6%
$2.98
$2.31
▼
$5.49
$38.27M1.18571,095 shs194,505 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CVS Health Corporation stock logo
CVS
CVS Health
0.00%+6.70%-3.34%-7.96%+11.10%
Haemonetics Corporation stock logo
HAE
Haemonetics
0.00%+2.74%+1.24%+35.54%+68.40%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
0.00%-18.53%-15.88%-18.53%-49.35%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CVS Health Corporation stock logo
CVS
CVS Health
$89.37
-0.5%
$89.65
$69.51
▼
$110.68
$114.32B0.5811.03 million shs8.02 million shs
Haemonetics Corporation stock logo
HAE
Haemonetics
$123.16
+0.4%
$113.34
$51.00
▼
$132.00
$5.60B0.62685,220 shs439,677 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$2.33
-27.6%
$2.98
$2.31
▼
$5.49
$38.27M1.18571,095 shs194,505 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CVS Health Corporation stock logo
CVS
CVS Health
0.00%+6.70%-3.34%-7.96%+11.10%
Haemonetics Corporation stock logo
HAE
Haemonetics
0.00%+2.74%+1.24%+35.54%+68.40%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
0.00%-18.53%-15.88%-18.53%-49.35%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CVS Health Corporation stock logo
CVS
CVS Health
2.92
Moderate Buy$107.5420.34% Upside
Haemonetics Corporation stock logo
HAE
Haemonetics
2.83
Moderate Buy$129.004.74% Upside
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
2.60
Moderate Buy$5.83150.36% Upside

Current Analyst Ratings Breakdown

Latest SRTS, HAE, and CVS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/13/2026
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
DowngradeSell (D-) ➝ Sell (E+)
11/13/2026
CVS Health Corporation stock logo
CVS
CVS Health
Set Price Target$106.00
11/13/2026
CVS Health Corporation stock logo
CVS
CVS Health
Reiterated RatingOutperform
11/13/2026
Haemonetics Corporation stock logo
HAE
Haemonetics
Initiated CoverageBuy$150.00
11/12/2026
CVS Health Corporation stock logo
CVS
CVS Health
Lower Price TargetOverweight$123.00 ➝ $112.00
11/9/2026
CVS Health Corporation stock logo
CVS
CVS Health
UpgradeHold (C+) ➝ Buy (B-)
11/6/2026
CVS Health Corporation stock logo
CVS
CVS Health
Set Price Target$103.00
11/6/2026
Haemonetics Corporation stock logo
HAE
Haemonetics
Boost Price TargetBuy$123.00 ➝ $149.00
11/6/2026
Haemonetics Corporation stock logo
HAE
Haemonetics
Boost Price TargetOutperform$140.00 ➝ $145.00
11/5/2026
Haemonetics Corporation stock logo
HAE
Haemonetics
Set Price Target$165.00
11/5/2026
CVS Health Corporation stock logo
CVS
CVS Health
Lower Price TargetBuy$118.00 ➝ $107.00
(Data available from 11/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CVS Health Corporation stock logo
CVS
CVS Health
$402.07B0.28$14.89 per share6.00$59.38 per share1.51
Haemonetics Corporation stock logo
HAE
Haemonetics
$1.33B4.20$7.59 per share16.22$17.14 per share7.19
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$27.48M1.40N/AN/A$2.93 per share0.80
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CVS Health Corporation stock logo
CVS
CVS Health
$1.77B$8.5910.7310.340.782.62%13.65%4.20%N/A
Haemonetics Corporation stock logo
HAE
Haemonetics
$97.31M$2.2324.1520.492.467.52%27.42%9.77%N/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-$7.72M-$0.97N/AN/AN/A-96.49%-23.79%-21.29%N/A

Latest SRTS, HAE, and CVS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/12/2026Q3 2026
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-$0.0550-$0.09-$0.0350-$0.09$6.61 million$6.00 million
11/5/2026Q2 2027
Haemonetics Corporation stock logo
HAE
Haemonetics
$1.29$1.35+$0.06$1.00$345.15 million$357.76 million
11/4/2026Q3 2026 & Investor update
CVS Health Corporation stock logo
CVS
CVS Health
$1.65$2.09+$0.44$1.68$104.72 billion$108.40 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
CVS Health Corporation stock logo
CVS
CVS Health
$2.662.98%+5.87%30.97%4 Years
Haemonetics Corporation stock logo
HAE
Haemonetics
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A

Latest SRTS, HAE, and CVS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/30/2026
CVS Health Corporation stock logo
CVS
CVS Health
quarterly$0.66502.81%10/22/202610/22/202611/2/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CVS Health Corporation stock logo
CVS
CVS Health
0.71
0.85
0.66
Haemonetics Corporation stock logo
HAE
Haemonetics
1.24
2.84
1.83
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
8.71
4.30

Institutional Ownership

CompanyInstitutional Ownership
CVS Health Corporation stock logo
CVS
CVS Health
80.66%
Haemonetics Corporation stock logo
HAE
Haemonetics
99.67%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%

Insider Ownership

CompanyInsider Ownership
CVS Health Corporation stock logo
CVS
CVS Health
0.85%
Haemonetics Corporation stock logo
HAE
Haemonetics
2.07%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
10.20%
CompanyEmployeesShares OutstandingFree FloatOptionable
CVS Health Corporation stock logo
CVS
CVS Health
300,0001.28 billion1.27 billionOptionable
Haemonetics Corporation stock logo
HAE
Haemonetics
3,00945.54 million44.60 millionOptionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
6016.46 million14.78 millionOptionable

Recent News About These Companies

Sensus Healthcare收跌27.8%,成交额50.28万美元
Sensus Healthcare (SRTS) Q3 2026 Earnings Call Transcript
Transcript : Sensus Healthcare, Inc., Q3 2026 Earnings Call, Nov 12, 2026
What Sensus Healthcare (SRTS) Said on Its Q3 Earnings Call
Sensus Healthcare收涨3.33%,成交额23.51万美元
Sensus Healthcare收涨3.77%,成交额51.32万美元
Sensus Healthcare收涨11.19%,成交额38.78万美元
Sensus Healthcare收跌10.15%,成交额43.12万美元
Sensus Healthcare (SRTS) Set to Post Quarterly Earnings on Thursday
Sensus Healthcare收跌1.07%,成交额160.87万美元
Sensus Healthcare收跌0.36%,成交额3.69万美元
Sensus Healthcare收跌1.77%,成交额4.88万美元
Sensus Healthcare收跌1.06%,成交额16.79万美元
Sensus Healthcare收涨1.08%,成交额28.2万美元

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
CVS Health stock logo

CVS Health NYSE:CVS

$89.37 -0.42 (-0.47%)
Closing price 11/13/2026 03:59 PM Eastern
Extended Trading
$89.18 -0.19 (-0.21%)
As of 11/13/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

Haemonetics stock logo

Haemonetics NYSE:HAE

$123.16 +0.45 (+0.36%)
Closing price 11/13/2026 03:59 PM Eastern
Extended Trading
$124.25 +1.09 (+0.89%)
As of 11/13/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 app. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$2.33 -0.89 (-27.64%)
Closing price 11/13/2026 04:00 PM Eastern
Extended Trading
$2.44 +0.11 (+4.51%)
As of 11/13/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.